Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.38 Analyst target: $12.50 Upside: 805.80%
CEL-SCI Corporation is dedicated to the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company is headquartered in Vienna, Virginia.
See the full interactive analysis & chart →Informational only — not investment advice.